Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 6, 2010, Pages 859-862

  Fujii, Masahiro ^a   Miyagi, Yasuo ^a   Bessho, Ryuzo ^a   Nitta, Takashi ^a   Ochi, Masami ^a   Shimizu, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bronchoscopic microsampling; Cardiopulmonary bypass; Inflammatory mediators; Neutrophil elastase; Sivelestat

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; SIVELESTAT;

ACUTE LUNG INJURY; ADULT; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD OXYGEN TENSION; BRONCHOSCOPY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTRACHEAL INTUBATION; ENZYME BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG LAVAGE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPREGULATION;

ACUTE LUNG INJURY; AGED; ANTI-INFLAMMATORY AGENTS; AORTIC VALVE; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CARDIOPULMONARY BYPASS; FEMALE; GLYCINE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE ELASTASE; LUNG; MALE; MIDDLE AGED; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PULMONARY GAS EXCHANGE; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954544246     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.225243     Document Type: Article

References (13)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-559.
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676-692.
3. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia 1992;47:267-268.
4. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO-5046-Na, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commum 1991;177:814-820.
5. Yamazaki T, Ooshima H, Usui A, Watanabe T, Yasuura K. Protective effects of ONO-5046*Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 1999;68:2141-2146.
6. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol 2001;69:241-247.
7. Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med 1998;26:1194-1199.
8. Ishizaka A, Watanabe M, Yamashita T, Ogawa Y, Koh H, Hasegawa N, Nakamura H, Asano K, Yamaguchi K, Kotani M, Kotani T, Morisaki H, Takeda J, Kobayashi K, Ogawa S. New bronchoscopic microsample probe to measure the biochemical constituents in alveolar of patients with acute respiratory distress syndrome. Crit Care Med 2001;29:896-898.
9. Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR, DeFoe GR, Dickinson TA, Gardner TJ, Grocott HP, O'Connor GT, Roshinski DJ, Sellke FW, Willcox TW. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006;132:283-290.
10. Gott JP, Cooper WA, Schmidt FE Jr, Brown WM III, Wright CE, Merlino JD, Fortenberry JD, Clark WS, Guyton RA. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. Ann Thorac Surg 1998;66:747-753; discussion 753-754.
11. Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 2005;80:611-617.
12. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
13. Kotani N, Hashimoto H, Sessler DI, Muraoka M, Wang JS, O'Connor MF, Matsuki A. Neutrophil number and interleukin-8 and elastase concentrations in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass. Anesth Analg 2000;90:1046-1051.